INDV Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 birž. 2024 @ 23:00):
Our systems believe the stock currently is overvalued by 0.00% compare to its pairs and should correct downwards.

Stats
Dzisiejszy wolumen	151 972
Średni wolumen	96 903
Kapitalizacja rynkowa	2.18B
Następna data zysków	( $0.460 ) 2024-07-25
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	407.00 (Sector) 42.63 (Industry) 30.78
ATR14	$0.0180 (0.11%)

AERI 0.00%

ALVO -4.13%

ALVOW -0.58%

BDSI -0.09%

BFRIW 0.00%

CLVRW 0.00%

CYTHW 9.05%

ENDP 0.00%

GRVI 7.61%

HPCO -1.47%

INDV -2.05%

JUPWW -20.00%

LFCR -6.56%

LNDC -3.52%

LSDI -2.40%

PRFX -2.97%

PROCW -12.75%

QLI -5.00%

SBFMW -9.33%

SHOT -8.77%

SHPH -0.25%

Korelacja (AI algo v.1.1b): Overvalued: 0.00% $16.28 paired level. (Algorytm śledzi zmiany najbardziej skorelowanych akcji w czasie rzeczywistym i natychmiast aktualizuje)

Wolumen Korelacja

Długi: -0.16 (neutral)

Krótki: 0.79 (moderate)

Signal:(46.935) Neutral

Indivior PLC Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Indivior PLC Korelacja - Waluta/Towar

0.42
( neutral )

0.67
( moderate )

0.00
( neutral )

0.19
( neutral )

0.23
( neutral )

-0.72
( moderate negative )

Financial Reports:

No articles found.

Indivior PLC Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Indivior PLC

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose. Its core marketed products include SUBLOCADE and SUBUTEX PRO buprenorphine extended-release monthly injections; SUBOXONE, a buprenorphine and naloxone sublingual film; SUBOXONE, a buprenorphine and naloxone sublingual tablet; and SUBUTEX, a buprenorphine sublingual tablet for the treatment of opioid use disorder. The company also offers OPVEE nasal spray for opioid overdose reversal; and PERSERIS extended-release injectable suspension for the treatment of schizophrenia in adults. In addition, it is developing INDV-2000, a selective orexin-1 receptor antagonist that completed phase 1 clinical trial for the treatment of opioid use disorder (OUD); INDV-1000, a selective GABAb positive allosteric modulator, which is in pre-clinical development phase for the treatment of alcohol use disorder in collaboration with ADDEX therapeutics; INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc.; and CT-102, a digital therapeutic for the treatment of OUD in collaboration with Click Therapeutics. Further, the company is developing INDV-5004, a drinabant injection to treat acute cannabinoid overdose. It has a strategic partnership with Aelis Farma to develop AEF0117, a synthetic CB1 specific signaling inhibitor that is in phase 2B clinical trial for the treatment of cannabis use disorder. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.